A downtrend has been apparent in Gamida Cell (GMDA) lately. While the stock has lost 15.6% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last ...
Is Gamida Cell Ltd. (NASDAQ:GMDA) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on ...
Gamida Cell Ltd. GMDA was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal ...
Gamida Cell (NASDAQ:GMDA) lost ~32% on Tuesday after the Israel-based cell therapy developer posted worse-than-expected revenue for Q3 2023, during which the company launched its commercial operations ...
Gamida Cell (NASDAQ:GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning Omisirge. Omisirge is the company’s cell therapy designed to treat patients with hematologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results